Sherko Kümmel

20.8k citations
227 papers · 5.0k · 1 hit paper · h-index 37

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 1%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology

Papers in

    • Cancer Treatment and Pharmacology 62
    • HER2/EGFR in Cancer Research 46
    • Cancer Immunotherapy and Biomarkers 25
    • Breast Cancer Treatment Studies 107
    • Cancer Genomics and Diagnostics 24

Sherko Kümmel

219 papers receiving 4.8k citations

Sherko Kümmel's Hit Papers

Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 2024 · 47 citations
470+1Years since publication10203040

Peers

Sherko Kümmel
Comparison fields: 5 of 137
  • Cancer Research 2.0k
  • Oncology 2.5k
  • Pathology and Forensic Medicine 910
  • Radiology, Nuclear Medicine and Imaging 1.0k
  • Hepatology 330
Replace Luigi Dogliotti with:
Luigi Dogliotti Italy
Nadeem Q. Mirza United States
Sarkis Meterissian Canada
Donn C. Young United States
Mijin Yun South Korea
David K. Gaffney United States
Shin‐Cheh Chen Taiwan
David J. Vaughn United States
Roy M. Bremnes Norway
Guy Jérusalem Belgium
Sherko Kümmel relative to Luigi Dogliotti Italy Luigi Dogliotti's profile →
Citations per field
00.5×1.5×2.5×
Luigi Dogliotti · 1×
Citations per year

Countries citing papers authored by Sherko Kümmel

Since Specialization
Citations

This map shows the geographic impact of Sherko Kümmel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherko Kümmel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherko Kümmel more than expected).

Fields of papers citing papers by Sherko Kümmel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherko Kümmel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherko Kümmel. The network helps show where Sherko Kümmel may publish in the future.

Co-authors

The 25 scholars most cited alongside Sherko Kümmel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sherko Kümmel Line = papers co-authored together Sherko Kümmel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 227 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1996388
2 2013265
3 2008210
4 2017194
5 2006194
6 2008182
7 2007128
8 2007117
9 2012116
10 2018112
11 201595
12 200692
13 201785
14 202183
15 201478
16 201577
17 199674
18 201466
19 201566
20 201162

About Sherko Kümmel

Sherko Kümmel is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery, having authored 227 papers that have together received 5.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (107 papers), Cancer Treatment and Pharmacology (62 papers), Advanced Breast Cancer Therapies (48 papers), HER2/EGFR in Cancer Research (46 papers), Breast Lesions and Carcinomas (33 papers), Cancer Immunotherapy and Biomarkers (25 papers), Cancer Genomics and Diagnostics (24 papers) and Complementary and Alternative Medicine Studies (20 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (2.5k citations), Pathology and Forensic Medicine (910 citations), Radiology, Nuclear Medicine and Imaging (1.0k citations) and Hepatology (330 citations). Sherko Kümmel has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Jens‐Uwe Blohmer, Sibylle Loibl, Gϋnter von Minckwitz, Christian Jackisch, Holger Cramer, Holger Eidtmann, Claus Hanusch, Carsten Denkert, Thomas Fischer and Michael Untch. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Breast Care and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact